دورية أكاديمية
أعرض في EDS

Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19.

التفاصيل البيبلوغرافية
العنوان: Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19.
المؤلفون: Wilson JC; Department of Mathematics, University of York, York YO10 5DD, UK., Kealy D; Hull York Medical School, University of York, Wentworth Way, York YO10 5DD, UK.; York Biomedical Research Institute, University of York, York YO10 5DD, UK., James SR; York Biosciences Technology Facility, University of York, Wentworth Way, York YO10 5DD, UK., Plowman T; Hull York Medical School, University of York, Wentworth Way, York YO10 5DD, UK.; York Biomedical Research Institute, University of York, York YO10 5DD, UK., Newling K; York Biosciences Technology Facility, University of York, Wentworth Way, York YO10 5DD, UK., Jagger C; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Room 2.16, 46 Grafton Street, Manchester M13 9PL, UK., Filbey K; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Room 2.16, 46 Grafton Street, Manchester M13 9PL, UK., Mann ER; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Room 2.16, 46 Grafton Street, Manchester M13 9PL, UK.; Maternal and Fetal Health Centre, Division of Developmental Biology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 5th Floor St. Mary's Hospital, Oxford Road, Manchester M13 9WL, UK., Konkel JE; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Room 2.16, 46 Grafton Street, Manchester M13 9PL, UK., Menon M; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Room 2.16, 46 Grafton Street, Manchester M13 9PL, UK., Knight SB; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Room 2.16, 46 Grafton Street, Manchester M13 9PL, UK.; Respiratory Department, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK., Simpson A; Division of Infection, Immunity and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK., Prihartadi A; Hull York Medical School, University of York, Wentworth Way, York YO10 5DD, UK., Forshaw G; York and Scarborough Teaching Hospitals NHS Foundation Trust, York YO31 8HE, UK., Todd N; York and Scarborough Teaching Hospitals NHS Foundation Trust, York YO31 8HE, UK., Yates DRA; Hull York Medical School, University of York, Wentworth Way, York YO10 5DD, UK.; The Members of the Coronavirus Immune Response and Clinical Outcomes (CIRCO) Collaborative Group., Grainger JR; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Room 2.16, 46 Grafton Street, Manchester M13 9PL, UK., Hussell T; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Room 2.16, 46 Grafton Street, Manchester M13 9PL, UK., Kaye PM; Hull York Medical School, University of York, Wentworth Way, York YO10 5DD, UK.; York Biomedical Research Institute, University of York, York YO10 5DD, UK., Signoret N; Hull York Medical School, University of York, Wentworth Way, York YO10 5DD, UK.; York Biomedical Research Institute, University of York, York YO10 5DD, UK., Lagos D; Hull York Medical School, University of York, Wentworth Way, York YO10 5DD, UK.; York Biomedical Research Institute, University of York, York YO10 5DD, UK.
مؤلفون مشاركون: CIRCO Collaborative Group
المصدر: IScience [iScience] 2022 Jan 21; Vol. 25 (1), pp. 103672. Date of Electronic Publication: 2021 Dec 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Cambridge, MA] : Cell Press, [2018]-
مستخلص: Inflammatory cytokines and chemokines (CC) drive COVID-19 pathology. Yet, patients with similar circulating CC levels present with different disease severity. Here, we determined 171 microRNAomes from 58 hospitalized COVID-19 patients (Cohort 1) and levels of 25 cytokines and chemokines (CC) in the same samples. Combining microRNA (miRNA) and CC measurements allowed for discrimination of severe cases with greater accuracy than using miRNA or CC levels alone. Severity group-specific associations between miRNAs and COVID-19-associated CC (e.g., IL6, CCL20) or clinical hallmarks of COVID-19 (e.g., neutrophilia, hypoalbuminemia) separated patients with similar CC levels but different disease severity. Analysis of an independent cohort of 108 patients from a different center (Cohort 2) demonstrated feasibility of CC/miRNA profiling in leftover hospital blood samples with similar severe disease CC and miRNA profiles, and revealed CCL20, IL6, IL10, and miR-451a as key correlates of fatal COVID-19. These findings highlight that systemic miRNA/CC networks underpin severe COVID-19.
Competing Interests: The authors declare no competing interests.
(© 2021 The Author(s).)
References: Clin Immunol. 2020 Nov;220:108576. (PMID: 32866645)
Noncoding RNA. 2021 Aug 31;7(3):. (PMID: 34564316)
Am J Hematol. 2020 Jul;95(7):834-847. (PMID: 32282949)
Life Sci. 2020 May 1;248:117473. (PMID: 32114007)
Cell. 2020 Jun 25;181(7):1475-1488.e12. (PMID: 32479746)
PLoS Pathog. 2021 Jul 28;17(7):e1009759. (PMID: 34320031)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
J Infect Dis. 2020 Aug 4;222(5):746-754. (PMID: 32563194)
Nucleic Acids Res. 2018 Jul 2;46(W1):W180-W185. (PMID: 29878154)
Biochim Biophys Acta. 2010 Dec;1806(2):200-7. (PMID: 20637263)
J Clin Invest. 2020 May 1;130(5):2620-2629. (PMID: 32217835)
Nature. 2021 Jul;595(7866):283-288. (PMID: 34010947)
BMJ. 2014 Dec 19;349:g7731. (PMID: 25527114)
Noncoding RNA. 2021 Sep 22;7(4):. (PMID: 34698261)
Front Med (Lausanne). 2020 Nov 03;7:566591. (PMID: 33224959)
Int J Mol Sci. 2021 Sep 26;22(19):. (PMID: 34638691)
Exp Cell Res. 2011 Mar 10;317(5):613-9. (PMID: 21376174)
Front Physiol. 2021 Apr 15;12:652579. (PMID: 33935804)
Front Immunol. 2021 Apr 26;12:668507. (PMID: 33981314)
Sci Rep. 2021 Sep 27;11(1):19161. (PMID: 34580386)
Eur J Immunol. 2021 Jun;51(6):1535-1538. (PMID: 33768543)
Nat Commun. 2021 Jul 5;12(1):4117. (PMID: 34226537)
Clin Chim Acta. 2020 Jul;506:145-148. (PMID: 32178975)
Cells. 2021 Sep 12;10(9):. (PMID: 34572043)
Nat Med. 2021 May;27(5):904-916. (PMID: 33879890)
Biomedicines. 2020 Oct 30;8(11):. (PMID: 33143053)
Sci Immunol. 2020 Sep 17;5(51):. (PMID: 32943497)
Cell. 2021 Apr 1;184(7):1836-1857.e22. (PMID: 33713619)
Postgrad Med J. 2022 Nov 1;98(1165):871-879. (PMID: 37063032)
Am J Respir Crit Care Med. 2020 Dec 1;202(11):1509-1519. (PMID: 32866033)
Nat Rev Immunol. 2020 Jul;20(7):407. (PMID: 32461673)
Nat Immunol. 2020 Dec;21(12):1506-1516. (PMID: 33028979)
Meta Gene. 2022 Feb;31:100990. (PMID: 34722158)
Front Immunol. 2017 Feb 16;8:118. (PMID: 28261201)
Int Immunopharmacol. 2021 Dec;101(Pt A):108172. (PMID: 34601331)
Autoimmunity. 2014 Nov;47(7):419-29. (PMID: 24953646)
Immunity. 2021 Jun 8;54(6):1257-1275.e8. (PMID: 34051148)
J Clin Pathol. 2021 Nov;74(11):750-751. (PMID: 33067181)
Nat Med. 2020 Oct;26(10):1623-1635. (PMID: 32807934)
Cell Rep. 2021 Oct 19;37(3):109839. (PMID: 34624208)
Acta Biomed. 2020 Sep 07;91(3):e2020008. (PMID: 32921706)
Ann Palliat Med. 2021 Apr;10(4):3706-3714. (PMID: 33615814)
Front Immunol. 2020 May 01;11:827. (PMID: 32425950)
Drugs. 2021 Apr;81(5):517-531. (PMID: 33638807)
Mech Ageing Dev. 2021 Jan;193:111413. (PMID: 33307107)
Naunyn Schmiedebergs Arch Pharmacol. 2021 Nov;394(11):2187-2195. (PMID: 34590186)
Nature. 2020 Aug;584(7821):463-469. (PMID: 32717743)
Cell. 2020 Sep 17;182(6):1419-1440.e23. (PMID: 32810438)
Noncoding RNA. 2021 Feb 02;7(1):. (PMID: 33540664)
Nat Biotechnol. 2020 Aug;38(8):970-979. (PMID: 32591762)
EMBO Mol Med. 2021 Apr 9;13(4):e13191. (PMID: 33544398)
Int Immunopharmacol. 2021 Dec;101(Pt B):108201. (PMID: 34653729)
Cell. 2022 Mar 3;185(5):916-938.e58. (PMID: 35216673)
Sci Immunol. 2021 Mar 10;6(57):. (PMID: 33692097)
Transl Res. 2021 Oct;236:147-159. (PMID: 34048985)
Cell. 2021 Jan 7;184(1):149-168.e17. (PMID: 33278357)
J Allergy Clin Immunol. 2021 Jan;147(1):72-80.e8. (PMID: 33010257)
Nat Med. 2020 Oct;26(10):1636-1643. (PMID: 32839624)
Crit Care. 2021 Aug 25;25(1):306. (PMID: 34433473)
Sci Rep. 2016 Sep 13;6:32651. (PMID: 27623086)
JCI Insight. 2020 Jul 9;5(13):. (PMID: 32501293)
Nature. 2020 Mar;579(7798):265-269. (PMID: 32015508)
Elife. 2015 Aug 12;4:. (PMID: 26267216)
معلومات مُعتمدة: United Kingdom WT_ Wellcome Trust; 21927 United Kingdom VAC_ Versus Arthritis; MR/V028448/1 United Kingdom MRC_ Medical Research Council
فهرسة مساهمة: Keywords: Clinical finding; Complex system biology; Health sciences
تواريخ الأحداث: Date Created: 20211227 Latest Revision: 20230721
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC8686203
DOI: 10.1016/j.isci.2021.103672
PMID: 34957382
قاعدة البيانات: MEDLINE
الوصف
تدمد:2589-0042
DOI:10.1016/j.isci.2021.103672